𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

✍ Scribed by Dr. Charles N. Bernstein; Jayne Eaden; A. Hillary Steinhart; Pia Munkholm; Philip H. Gordon

Book ID
110086041
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
99 KB
Volume
8
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Colorectal cancer prevention in inflamma
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update
✍ David T. Rubin; Marcia R. Cruz-Correa; Christoph Gasche; Jeremy R. Jass; Gary R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 2 views

A roundtable consensus meeting was held to consolidate current knowledge on the etiology of colorectal cancer in patients with inflammatory bowel disease and to review current strategies, both diagnostic and preventive, specifically addressing the role of 5-aminosalicylic acid. Specific topics that

5-Aminosalicylic acid therapy and the ri
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective